Treating intracranial hypertension in patients with severe traumatic brain injury during neurointensive care: New features of old problems?

European Journal of Trauma

Volumn 31, Issue 4, 2005, Pages 308-330

  Stover, John F ^a   Steiger, Peter ^a   Stocker, Reto ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Brain edema; Critical care; Intracranial pressure; Neuromonitoring

Indexed keywords

ALDOSTERONE ANTAGONIST; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; ERGOTAMINE; FENTANYL; FUROSEMIDE; HYDROCORTISONE; INSULIN; LORAZEPAM; MANNITOL; METHYLPREDNISOLONE; MIDAZOLAM; MORPHINE; OPIATE; PROPOFOL; STEROID; THIOPENTAL; VASOPRESSIN RECEPTOR ANTAGONIST;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; BRAIN INJURY; BRAIN PERFUSION; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID DRAINAGE; CLINICAL PRACTICE; CLINICAL TRIAL; COCHRANE LIBRARY; CRANIECTOMY; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; ELECTROLYTE DISTURBANCE; ENDOCRINE DISEASE; ENERGY EXPENDITURE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; HUMAN; HYPERGLYCEMIA; HYPERNATREMIA; HYPERVENTILATION; HYPONATREMIA; IMMUNOPATHOLOGY; INDUCED HYPOTHERMIA; INFLAMMATION; INSULIN RESISTANCE; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; JUGULAR VEIN; MICRODIALYSIS; MYOPATHY; NEUROIMAGING; NEUROPATHY; NUTRITION; OXYGEN THERAPY; PATHOPHYSIOLOGY; PATIENT MONITORING; PNEUMONIA; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; VEIN CATHETERIZATION; WOUND INFECTION;

EID: 24044480062     PISSN: 14390590     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00068-005-2055-3     Document Type: Review

References (135)

1. Schoon P, Benito Mori L, Orlandi G, et al. Incidence of intracranial hypertension related to jugular bulb oxygen saturation disturbances in severe traumatic brain injury patients. Acta Neurochir Suppl (Wien) 2002;81:285-7.
2. Royo NC, Shimizu S, Schouten JW, et al. Pharmacology of traumatic brain injury. Curr Opin Pharmacol 2003;3:27-32.
3. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003;34:2518-32.
4. Stocchetti N, Penny KI, Dearden M, et al., European Brain Injury Consortium. Intensive care management of head-injured patients in Europe: a survey from the European brain injury consortium. Intensive Care Med 2001;27:400-6.
5. Chambers IR, Treadwell L, Mendelow AD. Determination of threshold levels of cerebral perfusion pressure and intracranial pressure in severe head injury by using receiver-operating characteristic curves: an observational study in 291 patients. J Neurosurg 2001;94:412-6.
6. 2. Br J Neurosurg 2003;17:311-8.
7. Young GB, Wang JT, Connolly JF. Prognostic determination in anoxic-ischemic and traumatic encephalopathies. J Clin Neurophysiol 2004;21:379-90.
8. Vespa PM, Nuwer MR, Nenov V, et al. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg 1999;91:750-60.
9. Claassen J, Mayer SA, Kowalski RG, et al. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004;62:1743-8.
10. Hillered L, Vespa PM, Hovda DA. Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J Neurotrauma 2005;22:3-41.
11. Ederoth P, Tunblad K, Bouw R, et al. Blood-brain barrier transport of morphine in patients with severe brain trauma. Br J Clin Pharmacol 2004;57:427-35.
12. Hutchinson PJ, O'Connell MT, Al-Rawi PG, et al. Clinical cerebral microdialysis: a methodological study. J Neurosurg 2000;93:37-43.
13. Chen KC, Hoistad M, Kehr J, et al. Theory relating in vitro and in vivo microdialysis with one or two probes. J Neurochem 2002;81:108-21.
14. Wagner AK, Bayir H, Ren D, et al. Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia. J Neurotrauma 2004;21:125-36.
15. Stover JF, Pleines UE, Morganti-Kossmann MC, et al. Thiopental attenuates energetic impairment but fails to normalize cerebrospinal fluid glutamate in brain-injured patients. Crit Care Med 1999;27:1351-7.
16. Stocchetti N, Canavesi K, Magnoni S, et al. Arterio-jugular difference of oxygen content and outcome after head injury. Anesth Analg 2004;99:230-4.
17. Suzuki M, Motohashi O, Nishino A, et al. Diphasic increase in thrombin-antithrombin III complex in blood from the internal jugular vein following severe head injury. Thromb Haemost 1994;71:155-7.
18. Suzuki M, Kudo A, Sugawara A, et al. Amino acid concentrations in the blood of the jugular vein and peripheral artery after traumatic brain injury: decreased release of glutamate into the jugular vein in the early phase. J Neurotrauma 2002;19:285-92.
19. Murshid WR, Gader AG. The coagulopathy in acute head injury: comparison of cerebral versus peripheral measurements of haemostatic activation markers. Br J Neurosurg 2002;16:362-9.
20. Suehiro E, Fujisawa H, Akimura T, et al. Increased matrix metalloproteinase-9 in blood in association with activation of interleukin-6 after traumatic brain injury: influence of hypothermic therapy. J Neurotrauma 2004;21:1706-11.
21. Coles JP, Minhas PS, Fryer TD, et al. Effect of hyperventilation on cerebral blood flow in traumatic head injury: clinical relevance and monitoring correlates. Crit Care Med 2002;30:1950-9.
22. Sarrafzadeh AS, Kiening KL, Callsen TA, et al. Metabolic changes during impending and manifest cerebral hypoxia in traumatic brain injury. Br J Neurosurg 2003;17:340-6.
23. Van den Brink WA, van Santbrink H, Steyerberg EW, et al. Brain oxygen tension in severe head injury. Neurosurgery 2000;46:868-76.
24. Fandino J, Stocker R, Prokop S, et al. Cerebral oxygenation and systemic trauma related factors determining neurological outcome after brain injury. J Clin Neurosci 2000;7:226-33.
25. 2 changes during moderate hyperventilation in patients with severe traumatic brain injury. J Neurosurg 2002;96:97-102.
26. Graham DI, Adams JH, Doyle D. Ischaemic brain damage in fatal non-missile head injuries. J Neurol Sci 1978;39:213-34.
27. Vajkoczy P, Roth H, Horn P, et al. Continuous monitoring of regional cerebral blood flow: experimental and clinical validation of a novel thermal diffusion microprobe. J Neurosurg 2000;93:265-74.
28. Jaeger M, Soehle M, Schuhmann MU, et al. Correlation of continuously monitored regional cerebral blood flow and brain tissue oxygen. Acta Neurochir (Wien) 2005;147:51-6.
29. Schutt S, Horn P, Roth H, et al. Bedside monitoring of cerebral blood flow by transcranial thermo-dye-dilution technique in patients suffering from severe traumatic brain injury or subarachnoid hemorrhage. J Neurotrauma 2001;18:595-605.
30. Van Santbrink H, Schouten JW, Steyerberg EW, et al. Serial transcranial Doppler measurements in traumatic brain injury with special focus on the early posttraumatic period. Acta Neurochir (Wien) 2002;144:1141-9.
31. Wintermark M, Chiolero R, van Melle G, et al. Relationship between brain perfusion computed tomography variables and cerebral perfusion pressure in severe head trauma patients. Crit Care Med 2004;32:1579-87.
32. Abu-Judeh HH, Parker R, Aleksic S, et al. SPECT brain perfusion findings in mild or moderate traumatic brain injury. Nucl Med Rev Cent East Eur 2000;3:5-11.
33. Sundgren PC, Reinstrup P, Romner B, et al. Value of conventional, and diffusion- and perfusion weighted MRI in the management of patients with unclear cerebral pathology, admitted to the intensive care unit. Neuroradiology 2002;44:674-80.
34. Maurer MH, Berger C, Wolf M, et al. The proteome of human brain microdialysate. Proteome Sci 2003;1:7.
35. Wolfla CE, Luerssen TG, Bowman RM, et al. Brain tissue pressure gradients created by expanding frontal epidural mass lesion. J Neurosurg 1996;84:642-7.
36. Sahuquillo J, Poca MA, Arribas M, et al. Interhemispheric supratentorial intracranial pressure gradients in head-injured patients: are they clinically important? J Neurosurg 1999;90:16-26.
37. Wu HM, Huang SC, Hattori N, et al. Subcortical white matter metabolic changes remote from focal hemorrhagic lesions suggest diffuse injury after human traumatic brain injury. Neurosurgery 2004;55:1306-17.
38. Elf K, Nilsson P, Enblad P. Outcome after traumatic brain injury improved by an organized secondary insult program and standardized neurointensive care. Crit Care Med 2002;30:2129-34.
39. Clayton TJ, Nelson RJ, Manara AR. Reduction in mortality from severe head injury following introduction of a protocol for intensive care management. Br J Anaesth 2004;93:761-7.
40. Fakhry SM, Trask AL, Waller MA, et al., IRTC Neurotrauma Task Force. Management of brain-injured patients by an evidence-based medicine protocol improves outcomes and decreases hospital charges. J Trauma 2004;56:492-9.
41. Forsyth RJ, Baxter P, Elliott T. Routine intracranial pressure monitoring in acute coma. Cochrane Database Syst Rev 2001;3:CD002043.
42. Grände PO, Asgeirsson B, Nordström CH. Volume-targeted therapy of increased intracranial pressure: the Lund concept unifies surgical and non-surgical treatments. Acta Anaesthesiol Scand 2002;46:929-41.
43. 15O PET imaging of cerebral physiology. J Cereb Blood Flow Metab 2004;24:191-201.
44. Furuya Y, Hlatky R, Valadka AB, et al. Comparison of cerebral blood flow in computed tomographic hypodense areas of the brain in head-injured patients. Neurosurgery 2003;52:340-5.
45. Robertson CS, Valadka AB, Hannay HJ, et al. Prevent ion of secondary ischemic insults after severe head injury. Crit Care Med 1999;27:2086-95.
46. Juul N, Morris GF, Marshall SB, et al. Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. The Executive Committee of the International Selfotel Trial. J Neurosurg 2000;92:1-6.
47. Clifton GL, Miller ER, Choi SC, et al. Fluid thresholds and outcome from severe brain injury. Crit Care Med 2002;30:739-45.
48. Vespa P. What is the optimal threshold for cerebral perfusion pressure following traumatic brain injury? Neurosurg Focus 2003;15:E4.
49. Nordstrom CH. Assessment of critical thresholds for cerebral perfusion pressure by performing bedside monitoring of cerebral energy metabolism. Neurosurg Focus 2003;15:E5.
50. Coles JP, Steiner LA, Johnston AJ, et al. Does induced hypertension reduce cerebral ischaemia within the traumatized human brain? Brain 2004;127:2479-90.
51. Johnston AJ, Steiner LA, Coles JP, et al. Effect of cerebral perfusion pressure augmentation on regional oxygenation and metabolism after head injury. Crit Care Med 2005;33:189-95.
52. Cremer OL, van Dijk GW, Amelink GJ, et al. Cerebral hemodynamic responses to blood pressure manipulation in severely head-injured patients in the presence or absence of intracranial hypertension. Anesth Analg 2004;99:1211-7.
53. Marion DW, Puccio A, Wisniewski SR, et al. Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury. Crit Care Med 2002;30:2619-25.
54. 2 reactivity and brain oxygen pressure monitoring in severe head injury. Crit Care Med 2000;28:3268-74.
55. Oertel M, Kelly DF, Lee JH, et al. Efficacy of hyperventilation, blood pressure elevation, and metabolic suppression therapy in controlling intracranial pressure after head injury. J Neurosurg 2002;97:1045-53.
56. Diringer MN, Videen TO, Yundt K, et al. Regional cerebrovascular and metabolic effects of hyperventilation after severe traumatic brain injury. J Neurosurg 2002;96:103-8.
57. Schroder ML, Muizelaar JP, Bullock MR, et al. Focal ischemia due to traumatic contusions documented by stable xenon-CT and ultra-structural studies. J Neurosurg 1995;82:966-71.
58. Salvant JB Jr, Muizelaar JP. Changes in cerebral blood flow and metabolism related to the presence of subdural hematoma. Neurosurgery 1993;33:387-93.
59. Laffey JG, Kavanagh BP. Hypocapnia. N Engl J Med 2002;347:43-53.
60. Schierhout G, Roberts I. Hyperventilation therapy for acute traumatic brain injury. Cochrane Database Syst Rev 2000;2:CD000566.
61. Roberts I, Schierhout G, Wakai A. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev 2003;2:CD001049.
62. Rosner MJ, Coley I. Cerebral perfusion pressure: hemodynamic mechanism of mannitol and the postmannitol hemogram. Neurosurgery 1987;21:147-56.
63. Cruz J, Minoja G, Okuchi K, et al. Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial. J Neurosurg 2004;100:376-83.
64. Kreimeier U, Messmer K. Small-volume resuscitation: from experimental evidence to clinical routine. Advantages and disadvantages of hypertonic solutions. Acta Anaesthesiol Scand 2002;46:625-38.
65. Munar F, Ferrer AM, de Nadal M, et al. Cerebral hemodynamic effects of 7.2% hypertonic saline in patients with head injury and raised intracranial pressure. J Neurotrauma 2000;17:41-51.
66. Vialet R, Albanese J, Thomachot L, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 2003;31:1683-7.
67. Horn P, Munch E, Vajkoczy P, et al. Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates. Neurol Res 1999;21:758-64.
68. Cooper DJ, Myles PS, McDermott FT, et al., HTS Study Investigators. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 2004;291:1350-7.
69. Battison C, Andrews PJ, Graham C, et al. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 2005;33:196-202.
70. Bunn F, Roberts I, Tasker R, et al. Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2004;3:CD002045.
71. Neff TA, Doelberg M, Jungheinrich C, et al. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 2003;96:1453-9.
72. Finfer S, Bellomo R, Boyce N, et al., SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-56.
73. Sonnewald U, Qu H, Aschner M. Pharmacology and toxicology of astrocyte-neuron glutamate transport and cycling. J Pharmacol Exp Ther 2002;301:1-6.
74. Nordström CH, Reinstrup P, Xu W, et al. Assessment of the lower limit for cerebral perfusion pressure in severe head injuries by bedside monitoring of regional energy metabolism. Anesthesiology 2003;98:809-14.
75. Roberts I. Barbiturates for acute traumatic brain injury. Cochrane Database Syst Rev 2000;2:CD000033.
76. Gemma M, Tommasino C, Cerri M, et al. Intracranial effects of endotracheal suctioning in the acute phase of head injury. J Neurosurg Anesthesiol 2002;14:50-4.
77. Chen Y, Swanson RA. Astrocytes and brain injury. J Cereb Blood Flow Metab 2003;23:137-49.
78. Citerio G, Cormio M. Sedation in neurointensive care: advances in understanding and practice. Curr Opin Crit Care 2003;9:120-6.
79. Lee JH, Kelly DF, Oertel M, et al. Carbon dioxide reactivity, pressure autoregulation, and metabolic suppression reactivity after head injury: a transcranial Doppler study. J Neurosurg 2001;95:222-32.
80. Marik PE. Propofol: therapeutic indications and side-effects. Curr Pharm Des 2004;10:3639-49.
81. Willis C., Lybrand S, Bellamy N. Excitatory amino acid inhibitors of traumatic brain injury. Cochrane Database Syst Rev 2004;1:CD003986.
82. Vasile B, Rasulo F, Candiani A, et al. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003;29:1417-25.
83. Vallejo R, de Leon-Casasola O, Benyamin R. Opioid therapy and immunosuppression: a review. Am J Ther 2004;11:354-65.
84. Marion DW. Controlled normothermia in neurologic intensive care. Crit Care Med 2004;32:S43-5.
85. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346:557-63.
86. Tokutomi T, Morimoto K, Miyagi T, et al. Optimal temperature for the management of severe traumatic brain injury: effect of hypothermia on intracranial pressure, systemic and intracranial hemodynamics, and metabolism. Neurosurgery 2003;52:102-11.
87. Polderman KH. Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality - part 2: Practical aspects and side effects. Intensive Care Med 2004;30:757-69.
88. McIntyre LA, Fergusson DA, Hebert PC, et al. Prolonged therapeutic hypothermia after traumatic brain injury in adults: a systematic review. JAMA 2003;289:2992-9.
89. Polderman KH, TjongTjin Joe R, Peerdeman SM, et al. Effects of therapeutic hypothermia on intracranial pressure and outcome in patients with severe head injury. Intensive Care Med 2002;28:1563-73.
90. Mayer SA, Kowalski RG, Presciutti M, et al. Clinical trial of a novel surface cooling system for fever control in neurocriticalcare patients. Crit Care Med 2004;32:2508-15.
91. Wang H, Olivero W, Lanzino G, et al. Rapid and selective cerebral hypothermia achieved using a cooling helmet. J Neurosurg 2004;100:272-7.
92. Keller E, Imhof HG, Gasser S, et al. Endovascular cooling with heat exchange catheters: a new method to induce and maintain hypothermia. Intensive Care Med 2003;29:939-43.
93. Malbrain ML, Deeren D, De Potter TJ. Intra-abdominal hypertension in the critically ill: it is time to pay attention. Curr Opin Crit Care 2005;11:156-71.
94. Joseph DK, Dutton RP, Aarabi B, et al. Decompressive laparotomy to treat intractable intracranial hypertension after traumatic brain injury. J Trauma 2004;57:687-93.
95. Citerio G, Vascotto E, Villa F, et al. Induced abdominal compartment syndrome increases intracranial pressure in neurotrauma patients: a prospective study. Crit Care Med 2001;29:1466-71.
96. Berger C, Sakowitz OW, Kiening KL, et al. Neurochemical monitoring of glycerol therapy in patients with ischemic brain edema. Stroke 2005;36:64-6.
97. Roberts I, Yates D, Sandercock P, et al., CRASH Trial Collaborators. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004;364:1321-38.
98. Dinkel K, MacPherson A, Sapolsky RM. Novel glucocorticoid effects on acute inflammation in the CNS. J Neurochem 2003;84:705-16.
99. Patel R, McIntosh L, McLaughlin J, et al. Disruptive effects of glucocorticoids on glutathione peroxidase biochemistry in hippocampal cultures. J Neurochem 2002;82:118-25.
100. Bondanelli M, De Marinis L, Ambrosio MR, et al. Occurrence of pituitary dysfunction following traumatic brain injury. J Neurotrauma 2004;21:685-96.
101. Agha A, Rogers B, Mylotte D, et al. Neuroendocrine dysfunction in the acute phase of traumatic brain injury. Clin Endocrinol (Oxf) 2004;60:584-91.
102. Agha A, Thornton E, O'Kelly P, et al. Posterior pituitary dysfunction after traumatic brain injury. J Clin Endocrinol Metab 2004;89:5987-92.
103. Agha A, Rogers B, Sherlock M, et al. Anterior pituitary dysfunction in survivors of traumatic brain injury. J Clin Endocrinol Metab 2004;89:4929-36.
104. Van den Berghe G, de Zegher F. Anterior pituitaryfunction during critical illness and dopamine treatment. Crit Care Med 1996;24:1580-90.
105. Dimopoulou I, Tsagarakis S, Douka E, et al. The low-dose corticotropin stimulation test in acute traumatic and non-traumatic brain injury: incidence of hypo-responsiveness and relationship to outcome. Intensive Care Med 2004;30:1216-9.
106. De Petris L, Luchetti A, Emma F. Cell volume regulation and transport mechanisms across the blood-brain barrier: implications for the management of hypernatraemic states. Eur J Pediatr 2001;160:71-7.
107. Massieu L, Montiel T, Robles G, et al. Brain amino acids during hyponatremia in vivo: clinical observations and experimental studies. Neurochem Res 2004;29:73-81.
108. Gross P, Reimann D, Henschkowski J, et al. Treatment of severe hyponatremia: conventional and novel aspects. J Am Soc Nephrol 2001;12:S10-4.
109. Lang F, Busch GL, Ritter M, et al. Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998;78:247-306.
110. Darbar A. Nutritional requirements in severe head injury. Nutrition 2001;17:71-2.
111. Stover JF, Kempski OS. Glutamate-containing parenteral nutrition doubles plasma glutamate: a risk factor in neurosurgical patients with blood-brain barrier damage? Crit Care Med 1999;27:2252-6.
112. Berard MP, Zazzo JF, Condat P, et al. Total parenteral nutrition enriched with arginine and glutamate generates glutamine and limits protein catabolism in surgical patients hospitalized in intensive care units. Crit Care Med 2000;28:3637-44.
113. Melis GC, ter Wengel N, Boelens PG, et al. Glutamine: recent developments in research on the clinical significance of glutamine. Curr Opin Clin Nutr Metab Care 2004;7:59-70.
114. Dechelotte P, Darmaun D, Rongier M, et al. Absorption and metabolic effects of enterally administered glutamine in humans. Am J Physiol 1991;260:G677-82.
115. Petersen SR, Jeevanandam M, Holaday NJ, et al. Arterial-jugular vein free amino acid levels in patients with head injuries: important role of glutamine in cerebral nitrogen metabolism. J Trauma 1996;41:687-94.
116. Scarna A, McTavish SF, Cowen PJ, et al. The effects of a branched chain amino acid mixture supplemented with tryptophan on biochemical indices of neurotransmitter function and decision-making. Psychopharmacology (Berl) 2005;179:761-8.
117. Zygun DA, Steiner LA, Johnston AJ, et al. Hyperglycemia and brain tissue pH after traumatic brain injury. Neurosurgery 2004;55:877-81.
118. Jeremitsky E, Omert LA, Dunham CM, et al. The impact of hyperglycemia on patients with severe brain injury. J Trauma 2005;58:47-50.
119. Hattori N, Huang SC, Wu HM, et al. Acute changes in regional cerebral (18)F-FDG kinetics in patients with traumatic brain injury. J Nucl Med 2004;45:775-83.
120. Diaz-Parejo P, Stahl N, Xu W, et al. Cerebral energy metabolism during transient hyperglycemia in patients with severe brain trauma. Intensive Care Med 2003;29:544-50.
121. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004;114:1187-95.
122. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-67.
123. McEwen BS, Reagan LP. Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur J Pharmacol 2004;490:13-24.
124. Mann GE, Yudilevich DL, Sobrevia L. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 2003;83:183-252.
125. Voll CL, Auer RN. The effect of postischemic blood glucose levels on ischemic brain damage in the rat. Ann Neurol 1988;24:638-46.
126. Strong AJ, Smith SE, Whittington DJ, et al. Factors influencing the frequency of fluorescence transients as markers of peri-infarct depolarizations in focal cerebral ischemia. Stroke 2000;31:214-22.
127. Parkin M, Hopwood S, Jones DA, et al. Dynamic changes in brain glucose and lactate in pericontusional areas of the human cerebral cortex, monitored with rapid sampling on-line microdialysis: relationship with depolarisation-like events. J Cereb Blood Flow Metab 2005;25:402-13.
128. Malhotra AK, Schweitzer JB, Fox JL, et al. Cerebral perfusion pressure elevation with oxygen-carrying pressor after traumatic brain injury and hypotension in Swine. J Trauma 2004;56:1049-57.
129. Tolias CM, Reinert M, Seiler R, et al. Normobaric hyperoxia-induced improvement in cerebral metabolism and reduction in intracranial pressure in patients with severe head injury: a prospective historical cohort-matched study. J Neurosurg 2004;101:435-44.
130. Rockswold SB, Rockswold GL, Vargo JM, et al. Effects of hyperbaric oxygenation therapy on cerebral metabolism and intracranial pressure in severely brain injured patients. J Neurosurg 2001;94:403-11.
131. Magnoni S, Ghisoni L, Locatelli M, et al. Lack of improvement in cerebral metabolism after hyperoxia in severe head injury: a microdialysis study. J Neurosurg 2003;98:952-8.
132. Lee PJ, Choi AM. Pathways of cell signaling in hyperoxia. Free Radic Biol Med 2003;35:341-50.
133. Dutton RP, McCunn M, Hyder M, et al. Factor Vlla for correction of traumatic coagulopathy. J Trauma 2004;57:709-18.
134. Xi G, Reiser G, Keep RF. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem 2003;84:3-9.
135. Mhatre M, Nguyen A, Kashani S, et al. Thrombin, a mediator of neurotoxicity and memory impairment. Neurobiol Aging 2004;25:783-93.